Article
Gene patents at the Supreme Court: Association for Molecular Pathology v. Myriad Genetics
2 May 2014
Abstract excerpt
In June 2013, the Supreme Court unanimously decided Assn. for Molecular Pathology v. Myriad Genetics Inc., ruling that isolated naturally occurring sequences of genomic DNA (gDNA) cannot be patented. The Court left open the possibility of patenting complementary DNA (cDNA)—synthetic DNA containing the same protein-coding information as a segment of natural DNA but omitting non-coding portions called introns—and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
